三人行(605168.SH):實控人等已耗資3792.80萬元增持30.102萬股
格隆匯6月25日丨三人行(605168.SH)公佈,公司實控人錢俊冬、崔蕾及錢俊冬控制的公司控股股東青島多多行投資有限公司及部分董監高、部分核心員工原擬於2021年4月23日起6個月內通過上交所交易系統增持公司股份,增持金額合計不低於4280萬元,合計不超過1.066億元。
截至2021年6月25日,全體增持主體通過上交所交易系統以集中競價方式合計累計增持公司股份30.102萬股,佔公司總股本的0.4320%,增持金額為3792.80萬元,合計增持金額佔該次增持計劃合計金額下限的88.62%,已超過該次增持計劃下限金額的50%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.